Biotech IPO fundraising success: Seaport’s $255M Upsized IPO
Seaport Therapeutics’ upsized U.S. IPO raised nearly $255 million and priced at the top of its marketed range, highlighting biotech IPO fundraising success.
Most important news & global events daily
Seaport Therapeutics’ upsized U.S. IPO raised nearly $255 million and priced at the top of its marketed range, highlighting biotech IPO fundraising success.
Your cart is currently empty!
Notifications